KRT10 (Keratin, type I cytoskeletal 10) variants and mutations
KRT10 (also known as Keratin, type I cytoskeletal 10) is a human protein-coding gene encoding a keratin, type I cytoskeletal 10 protein. It forms intermediate filaments with keratin 1 in differentiating epidermal keratinocytes, protecting the upper epidermis from mechanical stress. Dominant pathogenic variants cause epidermolytic ichthyosis, while specific mechanisms can produce ichthyosis with confetti. This analysis covers 926 KRT10 variants and mutations. Of these, 80% have computational variant effect predictions. Disease context includes epidermolytic hyperkeratosis 2A, autosomal dominant, epidermolytic ichthyosis, and congenital reticular ichthyosiform erythroderma. Example KRT10 variants include V3A, R4*, and R4P.
Variant analysis overview
- Gene: KRT10
- Protein: Keratin, type I cytoskeletal 10
- UniProt accession: P13645
- Organism: Homo sapiens
- Variants analyzed: 926
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 751 unspecified-consequence records; 5 stop lost; 1 stop retained variant; 35 in-frame deletions; 6 stop-gained variants; 33 synonymous variants; 54 missense variants; 22 frameshift variants; 23 in-frame insertions; 1 protein altering variant; 1 substitution
- Prediction scores: 740 variants have prediction scores (80% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: epidermolytic hyperkeratosis 2A, autosomal dominant, epidermolytic ichthyosis, congenital reticular ichthyosiform erythroderma, ichthyosis, annular epidermolytic 1, annular epidermolytic ichthyosis, epidermolytic hyperkeratosis 2B, autosomal recessive, pachyonychia congenita, epidermolytic palmoplantar keratoderma, 1, Palmoplantar keratoderma, hereditary palmoplantar keratoderma, autosomal dominant epidermolytic ichthyosis, ichthyosis histrix, Lambert type.
Protein structure and variant hotspots
- Protein features: 1 domains; 6 post-translational modification sites.
- Structural context: 334 variants have structural context.
- PTM context: 9 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable KRT10 variants
Examples include V3A, R4*, R4P, R4Q, Y5H, S6C, S8R, S8T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- V3A (p.Val3Ala), Ensembl rs1905496274, REVEL 0.18, CADD 21.00
- R4* (p.Arg4Ter), NCI-TCGA Cosmic COSV9951, CADD 35.00, Variant assessed as somatic; high impact.
- R4P (p.Arg4Pro), rs142158041, ClinGen CA8548383, ClinVar RCV001991857, 1000Genomes rs142158041, REVEL 0.53, CADD 14.60, Likely benign, not provided
- R4Q (p.Arg4Gln), 1000Genomes rs142158041, ESP rs142158041, ExAC rs142158041, TOPMed rs142158041, REVEL 0.21, CADD 12.90, Likely benign
- Y5H (p.Tyr5His), gnomAD rs1567713168, REVEL 0.31, CADD 21.40
- S6C (p.Ser6Cys), Ensembl rs1308079930
- S8R (p.Ser8Arg), TOPMed rs1905494765, REVEL 0.25, CADD 22.50
- S8T (p.Ser8Thr), gnomAD rs1402109732, REVEL 0.28, CADD 8.97
- K9E (p.Lys9Glu), TOPMed rs1905494547
- K9R (p.Lys9Arg), TOPMed rs1439412846, REVEL 0.17, CADD 14.40
- H10N (p.His10Asn), NCI-TCGA Cosmic COSV9950, REVEL 0.20, CADD 14.80, Variant assessed as somatic; moderate impact.
- S12F (p.Ser12Phe), NCI-TCGA Cosmic COSV5408, Variant assessed as somatic; moderate impact.
- S13F (p.Ser13Phe), rs1362444242, ClinGen CA399396747, ClinVar RCV003304137, gnomAD rs1362444242, REVEL 0.47, CADD 21.70, Uncertain significance, Inborn genetic diseases
- R15C (p.Arg15Cys), gnomAD rs1460257467, REVEL 0.63, CADD 23.50
- R15H (p.Arg15His), rs28411890, ClinGen CA8548382, ClinVar RCV002144601, 1000Genomes rs28411890, REVEL 0.25, CADD 18.00, Benign, not provided
- S16I (p.Ser16Ile), ESP rs146957992, ExAC rs146957992, TOPMed rs146957992, gnomAD rs146957992
- S16N (p.Ser16Asn), ESP rs146957992, ExAC rs146957992, TOPMed rs146957992, gnomAD rs146957992, REVEL 0.27, CADD 16.60
- S16T (p.Ser16Thr), ESP rs146957992, ExAC rs146957992, TOPMed rs146957992, gnomAD rs146957992
- G17R (p.Gly17Arg), ExAC rs754010566, TOPMed rs754010566, gnomAD rs754010566, REVEL 0.39, CADD 19.30, Uncertain significance, not provided
- G18* (p.Gly18Ter), NCI-TCGA Cosmic COSV5408, Variant assessed as somatic; high impact.
- G18E (p.Gly18Glu), NCI-TCGA Cosmic COSV5408, Variant assessed as somatic; moderate impact.
- G18R (p.Gly18Arg), Ensembl rs1905491896, REVEL 0.30, CADD 13.90
- G19E (p.Gly19Glu), gnomAD rs1439707359, REVEL 0.29, CADD 18.10
- G19R (p.Gly19Arg), TOPMed rs1905491501, REVEL 0.27, CADD 17.40
- G20E (p.Gly20Glu), Ensembl rs979616398
- G20R (p.Gly20Arg), Ensembl rs1345958671, REVEL 0.31, CADD 17.10
- G21E (p.Gly21Glu), rs1211426625, NCI-TCGA Cosmic COSV5408, gnomAD rs1211426625, AlphaMissense 0.36, MetaLR 0.34, Variant assessed as somatic; moderate impact.
- G22E (p.Gly22Glu), rs968911030, NCI-TCGA Cosmic COSV9950, TOPMed rs968911030, REVEL 0.33, CADD 20.70, Variant assessed as somatic; moderate impact.
- G22R (p.Gly22Arg), Ensembl rs1905490240, REVEL 0.28, CADD 19.70
- G23R (p.Gly23Arg), ExAC rs761851864, gnomAD rs761851864, REVEL 0.39, CADD 22.30
- G24E (p.Gly24Glu), rs556262610, ClinGen CA8548376, ClinVar RCV001358374, 1000Genomes rs556262610, REVEL 0.40, CADD 14.40, Uncertain significance, not provided
- C25F (p.Cys25Phe), 1000Genomes rs544264740, ExAC rs544264740, TOPMed rs544264740, gnomAD rs544264740, REVEL 0.18, CADD 8.29
- C25Y (p.Cys25Tyr), 1000Genomes rs544264740, ExAC rs544264740, TOPMed rs544264740, gnomAD rs544264740, REVEL 0.17, CADD 2.97
- G27R (p.Gly27Arg), ExAC rs775260580, gnomAD rs775260580, REVEL 0.19, CADD 9.99
- G28E (p.Gly28Glu), rs991121036, NCI-TCGA Cosmic COSV5408, NCI-TCGA Cosmic COSV5409, Ensembl rs991121036, AlphaMissense 0.32, MetaLR 0.24, Variant assessed as somatic; moderate impact.
- G29E (p.Gly29Glu), gnomAD rs959668929, REVEL 0.17, CADD 2.33
- V31E (p.Val31Glu), TOPMed rs1435728074, gnomAD rs1435728074, REVEL 0.18, CADD 10.20
- V31G (p.Val31Gly), TOPMed rs1435728074, gnomAD rs1435728074, REVEL 0.16, CADD 9.94
- V31L (p.Val31Leu), Ensembl rs1567712927, REVEL 0.12, CADD 6.38
- S32L (p.Ser32Leu), gnomAD rs1385274461
- S32P (p.Ser32Pro), rs1311821469, NCI-TCGA Cosmic COSV9951, gnomAD rs1311821469, REVEL 0.26, CADD 19.40, Variant assessed as somatic; moderate impact.
- S33F (p.Ser33Phe), rs151149062, ClinGen CA8548360, ClinVar RCV001332428, ClinVar RCV004692557, REVEL 0.30, CADD 21.90, Uncertain significance, not provided; Epidermolytic ichthyosis
- S33T (p.Ser33Thr), rs141187850, ClinGen CA8548361, ClinVar RCV003089251, ESP rs141187850, REVEL 0.21, CADD 8.96, Uncertain significance, not provided
- I36T (p.Ile36Thr), rs1158516720, ClinGen CA399396617, ClinVar RCV003683524, TOPMed rs1158516720, REVEL 0.21, CADD 20.60, Uncertain significance, not provided
- I36V (p.Ile36Val), gnomAD rs1343954667, REVEL 0.07, CADD 7.36
- S38C (p.Ser38Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S38N (p.Ser38Asn), Ensembl rs1905480887
- S39C (p.Ser39Cys), Ensembl rs2143154171
- S39N (p.Ser39Asn), ExAC rs770303156, gnomAD rs770303156, REVEL 0.21, CADD 19.90
- K40N (p.Lys40Asn), ExAC rs778362078, TOPMed rs778362078, gnomAD rs778362078, REVEL 0.25, CADD 16.30
- K40Q (p.Lys40Gln), ExAC rs747571094, gnomAD rs747571094, REVEL 0.20, CADD 21.10
- G41A (p.Gly41Ala), gnomAD rs1905478989, REVEL 0.23, CADD 13.80
- G41R (p.Gly41Arg), gnomAD rs1348226953, REVEL 0.37, CADD 13.30
- S42F (p.Ser42Phe), rs142050024, ClinGen CA8548355, ClinVar RCV002130600, 1000Genomes rs142050024, REVEL 0.38, CADD 23.10, Likely benign, not provided
- S42P (p.Ser42Pro), TOPMed rs1267227135, gnomAD rs1267227135, REVEL 0.36, CADD 25.50
- L43H (p.Leu43His), ExAC rs748594551, gnomAD rs748594551
- L43P (p.Leu43Pro), ExAC rs748594551, gnomAD rs748594551, REVEL 0.23, CADD 9.20
- G44A (p.Gly44Ala), Ensembl rs1223926402
- G44R (p.Gly44Arg), ESP rs145403476, ExAC rs145403476, gnomAD rs145403476, REVEL 0.35, CADD 23.30
- G45E (p.Gly45Glu), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- G46E (p.Gly46Glu), gnomAD rs1354551053, REVEL 0.36, CADD 23.70
- G46R (p.Gly46Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- F47L (p.Phe47Leu), TOPMed rs1288227754, gnomAD rs1288227754, REVEL 0.21, CADD 17.90
- F47S (p.Phe47Ser), gnomAD rs1231099404, REVEL 0.17, CADD 3.72
- S48T (p.Ser48Thr), ExAC rs766514106, gnomAD rs766514106, REVEL 0.16, CADD 15.80
- S49T (p.Ser49Thr), ExAC rs772718519, gnomAD rs772718519, REVEL 0.21, CADD 17.10
- G50R (p.Gly50Arg), ExAC rs751529374, gnomAD rs751529374, REVEL 0.22, CADD 18.80
- F52V (p.Phe52Val), NCI-TCGA TCGA novel, Ensembl rs1905475396, REVEL 0.29, CADD 18.10, Variant assessed as somatic; high impact.
- F52Y (p.Phe52Tyr), TOPMed rs997536761, gnomAD rs997536761, REVEL 0.22, CADD 18.80, Uncertain significance, Inborn genetic diseases
- S53G (p.Ser53Gly), NCI-TCGA Cosmic COSV9950, Variant assessed as somatic; moderate impact.
- S53N (p.Ser53Asn), rs146835683, ClinGen CA8548345, ClinVar RCV000513318, ESP rs146835683, REVEL 0.28, CADD 18.70, Uncertain significance, not provided
- G54D (p.Gly54Asp), ExAC rs764984381, REVEL 0.16, CADD 15.40
- G55S (p.Gly55Ser), ExAC rs759260763, TOPMed rs759260763
- S56C (p.Ser56Cys), NCI-TCGA Cosmic COSV5408, NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- S56F (p.Ser56Phe), gnomAD rs1465048070
- F57C (p.Phe57Cys), ExAC rs776096107, gnomAD rs776096107, REVEL 0.15, CADD 18.80
- F57V (p.Phe57Val), TOPMed rs1905472558, gnomAD rs1905472558, REVEL 0.16, CADD 16.50
- R59C (p.Arg59Cys), TOPMed rs1426584949, gnomAD rs1426584949, REVEL 0.20, CADD 19.50, Uncertain significance, Inborn genetic diseases
- R59H (p.Arg59His), ESP rs374581207, ExAC rs374581207, TOPMed rs374581207, gnomAD rs374581207, REVEL 0.30, CADD 21.30, Uncertain significance, not provided
- R59L (p.Arg59Leu), NCI-TCGA Cosmic COSV9951, Variant assessed as somatic; moderate impact.
- G60A (p.Gly60Ala), ExAC rs772848992, gnomAD rs772848992, REVEL 0.25, CADD 16.70
- S61R (p.Ser61Arg), gnomAD rs1905470168, REVEL 0.41, CADD 15.70
- S62P (p.Ser62Pro), ExAC rs748627169, TOPMed rs748627169, gnomAD rs748627169, REVEL 0.32, CADD 22.70
- S62T (p.Ser62Thr), ExAC rs748627169, TOPMed rs748627169, gnomAD rs748627169, REVEL 0.25, CADD 19.40
- G63C (p.Gly63Cys), ExAC rs779464426, TOPMed rs779464426, gnomAD rs779464426, REVEL 0.37, CADD 6.12
- G63S (p.Gly63Ser), ExAC rs779464426, TOPMed rs779464426, gnomAD rs779464426, REVEL 0.22, CADD 0.29
- G64E (p.Gly64Glu), gnomAD rs1235697336, REVEL 0.34, CADD 21.30
- G64R (p.Gly64Arg), ExAC rs755259243, gnomAD rs755259243, REVEL 0.19, CADD 19.00
- C66L (p.Cys66Leu), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- F67L (p.Phe67Leu), rs1277986520, ClinGen CA399396301, ClinVar RCV002726586, TOPMed rs1277986520, REVEL 0.15, CADD 8.26, Uncertain significance, not provided
- F67S (p.Phe67Ser), ExAC rs780082291, gnomAD rs780082291, REVEL 0.17, CADD 18.20
- F67Y (p.Phe67Tyr), ExAC rs780082291, gnomAD rs780082291, REVEL 0.18, CADD 14.30
- G68R (p.Gly68Arg), NCI-TCGA Cosmic COSV5408, NCI-TCGA Cosmic COSV9951, Variant assessed as somatic; moderate impact.
- G69C (p.Gly69Cys), TOPMed rs1323745980, gnomAD rs1323745980, REVEL 0.31, CADD 23.00
- G69D (p.Gly69Asp), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- G69S (p.Gly69Ser), TOPMed rs1323745980, gnomAD rs1323745980
- S71P (p.Ser71Pro), TOPMed rs1402981926, gnomAD rs1402981926, REVEL 0.26, CADD 17.20
- G72D (p.Gly72Asp), ExAC rs756224291, gnomAD rs756224291, REVEL 0.40, CADD 14.30
- Y74H (p.Tyr74His), ExAC rs750559702, gnomAD rs750559702, REVEL 0.13, CADD 14.70
- G76R (p.Gly76Arg), Ensembl rs1905466829
- L77S (p.Leu77Ser), Ensembl rs1905466374
- L77V (p.Leu77Val), Ensembl rs866362824
- G78A (p.Gly78Ala), gnomAD rs1395002512, REVEL 0.22, CADD 15.70
- G79D (p.Gly79Asp), Ensembl rs1905465737, REVEL 0.39, CADD 22.90
- F80C (p.Phe80Cys), Ensembl rs868488431
- G81R (p.Gly81Arg), Ensembl rs1905465285
- G83C (p.Gly83Cys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S84G (p.Ser84Gly), TOPMed rs1174008254, gnomAD rs1174008254, REVEL 0.14, CADD 0.54
- S84I (p.Ser84Ile), NCI-TCGA TCGA novel, REVEL 0.20, CADD 8.74, Variant assessed as somatic; moderate impact.
- F85L (p.Phe85Leu), TOPMed rs1435535065
- R86C (p.Arg86Cys), rs1319705744, NCI-TCGA Cosmic COSV5409, gnomAD rs1319705744, REVEL 0.17, AlphaMissense 0.43, Variant assessed as somatic; moderate impact.
- R86H (p.Arg86His), rs117610737, ClinGen CA8548329, ClinVar RCV001311882, ClinVar RCV003928836, REVEL 0.33, CADD 16.70, Benign/Likely benign, not provided
- G87R (p.Gly87Arg), TOPMed rs1905463513
- S91R (p.Ser91Arg), ExAC rs759192704, gnomAD rs759192704, REVEL 0.37, CADD 2.44, Uncertain significance, not provided
- S91T (p.Ser91Thr), TOPMed rs1905462651
- S93T (p.Ser93Thr), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- F94C (p.Phe94Cys), NCI-TCGA Cosmic COSV9950, Ensembl rs1905462016, REVEL 0.19, CADD 18.50, Variant assessed as somatic; moderate impact.
- G96E (p.Gly96Glu), NCI-TCGA TCGA novel, REVEL 0.47, CADD 22.60, Variant assessed as somatic; moderate impact.
- S97R (p.Ser97Arg), gnomAD rs1597822752, REVEL 0.20, CADD 8.52
- Y98D (p.Tyr98Asp), gnomAD rs1905461015, REVEL 0.32, CADD 15.00
- G99A (p.Gly99Ala), TOPMed rs1286205226, REVEL 0.32, CADD 15.60
- G99E (p.Gly99Glu), NCI-TCGA Cosmic COSV9951, Variant assessed as somatic; moderate impact.
- G99R (p.Gly99Arg), rs1441986571, NCI-TCGA Cosmic COSV5409, TOPMed rs1441986571, gnomAD rs1441986571, REVEL 0.58, AlphaMissense 0.10, Variant assessed as somatic; moderate impact.
- G100D (p.Gly100Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- I101N (p.Ile101Asn), 1000Genomes rs4261597, ESP rs4261597, ExAC rs4261597, TOPMed rs4261597, REVEL 0.20, CADD 9.82, Benign
- I101S (p.Ile101Ser), rs4261597, ClinGen CA8548324, ClinVar RCV002117882, UniProt VAR 058202, REVEL 0.21, CADD 8.16, Benign, not provided
- I101T (p.Ile101Thr), 1000Genomes rs4261597, ESP rs4261597, ExAC rs4261597, TOPMed rs4261597, REVEL 0.20, CADD 7.21, Benign
- F102C (p.Phe102Cys), 1000Genomes rs114467326, ESP rs114467326, ExAC rs114467326, TOPMed rs114467326, REVEL 0.19, CADD 2.05, Benign
- F102S (p.Phe102Ser), rs114467326, ClinGen CA8548323, ClinVar RCV002957158, 1000Genomes rs114467326, REVEL 0.28, CADD 1.36, Benign, not provided
- G103R (p.Gly103Arg), gnomAD rs917824457, REVEL 0.35, CADD 13.10
- G104R (p.Gly104Arg), gnomAD rs1320428973, REVEL 0.48, AlphaMissense 0.12
- G105A (p.Gly105Ala), gnomAD rs1244658350, REVEL 0.41, CADD 15.40
- G105S (p.Gly105Ser), TOPMed rs1905455888, REVEL 0.37, CADD 15.20
- S106G (p.Ser106Gly), gnomAD rs1905454990, REVEL 0.18, AlphaMissense 0.13
- G108R (p.Gly108Arg), rs774951544, ClinGen CA8548318, ClinVar RCV002809760, ClinVar RCV005059292, REVEL 0.46, CADD 19.60, Uncertain significance, not provided; Inborn genetic diseases
- G109R (p.Gly109Arg), TOPMed rs1399101061, gnomAD rs1399101061, REVEL 0.51, CADD 15.70
- S111N (p.Ser111Asn), Ensembl rs1324480291
- F112S (p.Phe112Ser), Ensembl rs867600474, REVEL 0.24, CADD 1.06
- G113D (p.Gly113Asp), rs371456379, ClinGen CA8548314, ClinVar RCV000841356, ESP rs371456379, REVEL 0.42, CADD 19.80, Likely benign, not provided
- G114R (p.Gly114Arg), TOPMed rs962273487
- G114W (p.Gly114Trp), TOPMed rs962273487
- S116G (p.Ser116Gly), 1000Genomes rs546321678, ExAC rs546321678, gnomAD rs546321678, REVEL 0.25, CADD 0.00
- S116R (p.Ser116Arg), ExAC rs781280510, TOPMed rs781280510, gnomAD rs781280510, REVEL 0.36, CADD 12.70
- G121S (p.Gly121Ser), rs568226045, NCI-TCGA Cosmic COSV5408, gnomAD rs568226045, REVEL 0.18, AlphaMissense 0.10, Variant assessed as somatic; moderate impact.
- F122L (p.Phe122Leu), 1000Genomes rs201879590, ExAC rs201879590, TOPMed rs201879590, gnomAD rs201879590, REVEL 0.20, CADD 14.10
- G123R (p.Gly123Arg), ExAC rs754935101, gnomAD rs754935101, REVEL 0.36, CADD 16.30
- G124E (p.Gly124Glu), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G124R (p.Gly124Arg), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G124V (p.Gly124Val), rs200060640, ClinGen CA8548304, ClinVar RCV003548364, 1000Genomes rs200060640, REVEL 0.19, CADD 12.10, Uncertain significance, not provided
- G125S (p.Gly125Ser), Ensembl rs267604859
- G126D (p.Gly126Asp), TOPMed rs1202552687
- G126R (p.Gly126Arg), 1000Genomes rs77919366, ESP rs77919366, ExAC rs77919366, TOPMed rs77919366, Benign
- G126S (p.Gly126Ser), rs77919366, ClinGen CA216584, ClinVar RCV000056489, ClinVar RCV002496745, REVEL 0.08, CADD 0.36, Benign/Likely benign, Congenital reticular ichthyosiform erythroderma; Epidermolytic ichthyosis; Annul
- G128R (p.Gly128Arg), ExAC rs750064098, TOPMed rs750064098, gnomAD rs750064098, REVEL 0.33, CADD 24.00
- G129E (p.Gly129Glu), ExAC rs767159695, gnomAD rs767159695, REVEL 0.46, CADD 23.90
- G129R (p.Gly129Arg), gnomAD rs1329187588, REVEL 0.44, CADD 24.20
- G130D (p.Gly130Asp), ExAC rs761352015, gnomAD rs761352015, REVEL 0.47, CADD 23.60
- G130S (p.Gly130Ser), TOPMed rs1905439861
- F131I (p.Phe131Ile), ExAC rs775004391, TOPMed rs775004391, gnomAD rs775004391, REVEL 0.20, CADD 13.80, Uncertain significance, not provided
- G132R (p.Gly132Arg), ExAC rs769111194, gnomAD rs769111194
- G132S (p.Gly132Ser), ExAC rs769111194, gnomAD rs769111194, REVEL 0.40, CADD 22.70
- G134A (p.Gly134Ala), Ensembl rs1567712156, REVEL 0.24, CADD 19.20
- G137R (p.Gly137Arg), Ensembl rs2143151215
- D138H (p.Asp138His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L142F (p.Leu142Phe), Ensembl rs1031046887, REVEL 0.29, CADD 17.80
- L142P (p.Leu142Pro), ExAC rs763494250, gnomAD rs763494250, REVEL 0.48, CADD 24.90
- S143C (p.Ser143Cys), rs563178579, NCI-TCGA Cosmic COSV9951, 1000Genomes rs563178579, ExAC rs563178579, AlphaMissense 0.54, MetaLR 0.43, Variant assessed as somatic; moderate impact.
- S143F (p.Ser143Phe), NCI-TCGA Cosmic COSV9951, Variant assessed as somatic; moderate impact.
- S143Y (p.Ser143Tyr), rs563178579, NCI-TCGA Cosmic COSV9951, 1000Genomes rs563178579, ExAC rs563178579, REVEL 0.46, AlphaMissense 0.54, Variant assessed as somatic; moderate impact.
- G144R (p.Gly144Arg), ESP rs146976249, ExAC rs146976249, TOPMed rs146976249, gnomAD rs146976249, REVEL 0.54, CADD 24.40
- E146K (p.Glu146Lys), NCI-TCGA Cosmic COSV9950, Variant assessed as somatic; moderate impact.
- M150R (p.Met150Arg), rs58901407, ClinGen CA124140, ClinVar RCV000056491, ClinVar RCV004593968, AlphaMissense 1.00, MetaLR 0.90, Pathogenic, Epidermolytic hyperkeratosis 2A, autosomal dominant
- M150T (p.Met150Thr), rs58901407, ClinGen CA124144, NCI-TCGA Cosmic COSV5409, ClinVar RCV000056490, AlphaMissense 1.00, MetaLR 0.90, Pathogenic, not provided
- Q151* (p.Gln151Ter), TOPMed rs1173005762
- N152I (p.Asn152Ile), TOPMed rs999491422, gnomAD rs999491422, REVEL 0.58, CADD 25.90
- L153P (p.Leu153Pro), rs2508781293, ClinGen CA399394816, ClinVar RCV003408554, Uncertain significance, KRT10-related disorder
- L153V (p.Leu153Val), rs61460100, ClinGen CA216586, ClinVar RCV000056492, Ensembl rs61460100, AlphaMissense 0.99, MetaLR 0.96, Pathogenic, not provided
- N154H (p.Asn154His), rs57784225, ClinGen CA124130, ClinVar RCV000056493, ClinVar RCV004593964, AlphaMissense 0.99, MetaLR 0.96, Pathogenic, Epidermolytic hyperkeratosis 2A, autosomal dominant
- N154K (p.Asn154Lys), rs2508781272, ClinGen CA399394789, ClinVar RCV003566475, Uncertain significance, not provided
- N154S (p.Asn154Ser), rs2143150923, ClinGen CA399394803, ClinVar RCV002001626, Ensembl rs2143150923, AlphaMissense 0.98, MetaLR 0.96, Likely pathogenic, not provided
Public KRT10 analysis runs
- KRT10 analysis run — KRT10 (926 variants) — completed 2026-08-22